Drug and Medical Device Product Liability Deskbook

Annual Subscription with Automatic Renewal

Have a question about discounted site licenses, billing options, Or opting out of automatic renewal/update services? Email us or call 1.877.807.8076.
As low as $723.00
In stock
SKU
674ONL
This timely guide covers all aspects of litigation involving drugs, medical devices, vaccines and other FDA-regulated prescription products.

FDA-regulated products now account for an estimated one-fifth of overall economic activity in the U.S. They have also been the focus of a litigation explosion. This timely guide covers all aspects of litigation involving drugs, medical devices, vaccines and other FDA-regulated prescription products.

The Drug and Medical Device Product Liability Deskbook includes: detailed coverage of: warning-related claims and defenses; other information-based theories; strict liability; FDA-related per se liability; preemption of common law tort claims by the Food, Drug & Cosmetic Act and FDA regulations; class actions in drug and medical device litigation; theories of liability asserted against entities other than manufacturers; practical issues involving litigation management; the use of expert witnesses; and many other important topics. The authors include practical coverage of “what a litigator needs to know about the FDA.” You'll also find out how plaintiffs and defendants can enhance their chances for success before litigation even commences.

Book #00674; looseleaf, one volume, 1,158 pages; published in 2004, updated as needed; no additional charge for updates during your subscription. Looseleaf print subscribers receive supplements. The online edition is updated automatically. ISBN: 978-1-58852-121-7.

Additional Information
SKU 674ONL
Division Name Law Journal Press
Volumes 1
Product Types Books
Brand Law Journal Press
Jurisdiction National
ISBN 978-1-58852-121-7
Page Count 1158
Edition 0
Write Your Own Review
You're reviewing:Drug and Medical Device Product Liability Deskbook
Anthony Vale
Anthony Vale is a partner in the Litigation Department of Pepper Hamilton LLP in Philadelphia. He has wide experience in mass tort litigation involving drugs, devices and chemicals. He has written and lectured widely on these topics at ABA, IADC, ACI, and DRI meetings.Mr. Vale was chair of the Class Action and Multiparty Litigation Committee of the International Association of Defense Counsel, chair of the Toxic Tort and Environmental Law Committee of ABA/TIPS, and a member of the CLE board of the American Bar Association Tort and Insurance Practice Section (ABA/TIPS). He has also served as president of the British American Chamber of Commerce of Greater Philadelphia.Mr. Vale received his LL.B. in 1972 from the University of Exeter in England and attended University of Pennsylvania Law School. He is admitted to practice in Pennsylvania and before the United States Supreme Court, the Third, Fifth and Eleventh Circuit Courts of Appeal, and several federal district courts.
James M. Beck
James M. Beck is counsel in the life sciences health industries group of Reed Smith LLP in Philadelphia. He has overseen the development of legal defenses, master briefs, and dispositive motions in numerous mass torts, including Seroquel, a Merck analgesic product, diet drugs, Baycol, and orthopedic bone screws. Orthopedic Bone Screw ended with summary judgments in more than 170 cases, and prevailing in every appeal. Mr. Beck is a member of the Product Liability Advisory Committee (PLAC) and has sat on PLAC’s case selection committee since 1997. He has written over 60 amicus curiae briefs on product liability issues for PLAC. In 2011, Mr. Beck was awarded the PLAC’s John P. Raleigh Award, the highest honor given by the organization to one of its members. This award recognizes Mr. Beck’s overall contributions to the law of product liability, making him the eighth recipient of the Raleigh award in the almost 30-year history of the PLAC. Mr. Beck has also prepared amicus briefs for the American Bar Association, the American Civil Liberties Union, the American Medical Association and several of its state affiliates, the Anti-Defamation League, the Business Roundtable, the Pennsylvania Defense Research Institute, the United States Chamber of Commerce, and the Washington Legal Foundation. Mr. Beck has been chair of the Publications Subcommittee of the Mass Torts Litigation Committee of the Litigation Section of the American Bar Association since 2002. He has been named Outstanding Subcommittee Chair three times, in 2003-04, 2006-07, and 2008-09. A graduate of Princeton University (B.A., cum laude, 1978) and the University of Pennsylvania Law School (J.D., 1982), Mr. Beck is admitted to practice in federal and state courts in Pennsylvania, in the Supreme Court of the United States, and has been admitted in various federal and state courts pro hac vice.
CHAPTER 1
INTRODUCTION


CHAPTER 2
State Common Law Claims Based Upon Informational Defects

§ 2.01 Introduction
§ 2.02 The Duty to Warn and the Unavoidably Unsafe Product Doctrine
[1] Unavoidably Unsafe Products and Design Defects
[2] Prescription Medical Devices and Biologics as Unavoidably Unsafe Products
[3] Case-by-Case Versus Categorical Application of the Unavoidably Unsafe Product Doctrine
§ 2.03 The Learned Intermediary Rule
[1] The Learned Intermediary Rule as the Distinctive Attribute of Litigation Involving Prescription Medical Products
[2] Who Is the Learned Intermediary?
[3] Exceptions to the Learned Intermediary Rule
§ 2.04 Adequacy of Warnings
[1] Criteria for an Adequate Warning
[2] Establishing the Adequacy of a Warning as a Matter of Law
§ 2.05 Establishing Causation in a Warning Case
[1] When an Inadequate Warning is Non-Causal
[2] Issues of Fact Concerning Warning Causation
[3] The Presumption That an Inadequate Warning is Causal
[4] Other Causation Issues in Warning Cases
§ 2.06 Overpromotion and Negligent Marketing Claims
§ 2.07 Implied Warranty Claims
§ 2.08 Express Warranty Claims
§ 2.09 Illegal Promotion and Marketing Claims
§ 2.10 Duty to Warn Claims Involving Direct Patient Warnings
§ 2.11 Warning Claims Brought by Prescribing Physicians
§ 2.12 Public Policy Considerations Underlying the Unavoidable Unsafe Product Doctrine and the Learned Intermediary Rule
§ 2.13 Fraud/Intentional Misrepresentation
§ 2.14 State Consumer Protection Acts
§ 2.15 Federal RICO Claims

CHAPTER 3
State Common Law Claims Based Upon Non-Informational Defects

§ 3.01 Introduction—Design Defect Claims
§ 3.02 Claims Sounding in Strict Liability
[1] Strict Liability—Pleading and Merger of Other Causes of Action
[2] Elements of Strict Liability Claims Brought Under the Restatement (Second) of Torts § 402A
[3] Requirement of an Unreasonably Dangerous Product
[4] The Unavoidably Unsafe Product Doctrine
[5] Requirements of Injury and Proximate Cause
§ 3.03 Design Defect Claims Under the Restatement (Third) of Torts: Products Liability
§ 3.04 Design Defect Claims Sounding in Negligence
§ 3.05 Manufacturing Defects
[1] Introduction
[2] The Restatement Formulation of Manufacturing Defect
[3] Plaintiff’s Prima Facie Manufacturing Defect Case
[4] Rebutting Plaintiff’s Prima Facie Case of Manufacturing Defect
§ 3.06 Medical Monitoring
§ 3.07 Independent Duty to Test
§ 3.08 Miscellaneous Claims
[1] Duty to Recall
[2] Restitution/Unjust Enrichment
[3] Lanham Act
[4] Redhibition
[5] Failure to Train
[6] Intentional/Negligent Infliction of Emotional Distress
[7] Miscellaneous Federal Claims
[8] Miscellaneous State Law Claims
§ 3.09 Market Share Liability
§ 3.10 Cognizable Injury

CHAPTER 4
The Federal Framework

§ 4.01 What Litigators Need to Know About the FDA
[1] Introduction
[2] FDA Approval Processes for Prescription Medical Products
[3] Post-Approval FDA Regulation
[4] Off-Label Use
§ 4.02 The Food

Satisfaction Guarantee: You will always have a full 30 days from receipt in which to review any book. If you don’t want the book, simply return it in resalable condition within 30 days of receipt and write “cancel” on the invoice. If you paid by credit or debit card you will receive a full refund of the purchase price (excluding return shipping & handling). eBook returns are only available if the eBook has not yet been downloaded and updates made available during any subscription term are not refundable.
For more information about online access and our downloadable EPUB format see our FAQ.

Copyright © 2019 ALM Media, LLC. All Rights Reserved.